ITRM Insider Trading

Insider Ownership Percentage: 9.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Iterum Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Iterum Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100k$0$100kTotal Insider BuyingTotal Insider Selling

Iterum Therapeutics Share Price & Price History

Current Price: $1.54
Price Change: +0.30 (1.20%)
As of 01/17/2025 05:00 PM ET

This chart shows the closing price history over time for ITRM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
FebMarAprMayJunJulAugSepOctNovDecJan$1.54Closing price on 01/20/25:

Iterum Therapeutics Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Iterum Therapeutics (NASDAQ:ITRM)

9.21% of Iterum Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ITRM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$51kbought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$2M-$1M$0$1M$2MTotal InflowsTotal Outflows
Iterum Therapeutics logo
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Read More on Iterum Therapeutics

Today's Range

Now: $1.54
Low: $1.47
High: $1.61

50 Day Range

MA: $1.86
Low: $1.36
High: $2.91

52 Week Range

Now: $1.54
Low: $0.81
High: $3.02

Volume

537,230 shs

Average Volume

677,344 shs

Market Capitalization

$42.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.33

Who are the company insiders with the largest holdings of Iterum Therapeutics?

Iterum Therapeutics' top insider investors include:
  1. Michael W Dunne (Director)
  2. Corey N Fishman (CEO)
Learn More about top insider investors at Iterum Therapeutics.